Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,036.00
Bid: 2,034.00
Ask: 2,038.00
Change: -24.00 (-1.17%)
Spread: 4.00 (0.197%)
Open: 2,068.00
High: 2,068.00
Low: 2,026.00
Prev. Close: 2,060.00
WEIR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Oil-for-Food

13 Dec 2010 07:02

RNS Number : 8088X
Weir Group PLC
13 December 2010
 



The Weir Group PLC

 

Oil for Food

 

Further to the announcement made by The Weir Group PLC ("Weir" or the "Company") on 22nd July, 2004 and the disclosures subsequently made in the Company's annual reports and accounts, Weir today announces that it has agreed with the Crown Office in Scotland to plead guilty to two charges of breaching UN sanctions in connection with a number of UN sanctioned Oil for Food programme contracts awarded between 2000 and 2002. 

 

Weir is to be formally charged with these offences later today and it is expected that the case will be heard at the High Court in Edinburgh on 14 December, 2010 following which sentence will be passed.

 

Following the guilty plea, the Company will be subject to a confiscation order in respect of its benefit from the offences. Subject to the Court's approval, the Company has agreed the amount of this confiscation order with the Crown at £13,945,962. In addition the Company will be liable to a fine, the amount of which will be decided by the Court following the hearing.

 

A further announcement will be made after the court hearing.

 

Lord Smith, Chairman of Weir, commented: "What happened was wrong. As I said in 2004, I am bitterly disappointed that this went on within the Weir Group. Since 2004, when we first disclosed the issue, we have radically overhauled procedures. A strong ethics culture is in place across the Group and it is the reference point for everything we do."

 

 

Enquiries:

The Weir Group PLC

0141 308 3726

Helen Walker

 

 

 

Maitland

020 7379 5151

Suzanne Bartch

 

Rowan Brown

 

 

 

 

Notes to editors

 

Background

 

In 2004 Weir discovered that during the course of 2000, at the request of certain Iraqi customers, trading terms were amended. As a result the prices payable on subsequent Oil for Food contracts were uplifted by £3.1 million. The Group did not retain such uplift payments as equivalent sums were paid to an agent acting on behalf of the Group subsidiaries.

 

The contracts related to the supply of pump equipment and spare parts for clean water supply and oil field water injection and pipelines.

 

Immediately Weir became aware of an issue it took immediate action: it commissioned an internal investigation and an external investigation of all contracts undertaken under the Oil-for-Food programme and made a public announcement. The external investigation was undertaken by independent legal advisers, Herbert Smith. The findings from the investigation are summarised above.

 

Following the investigations, the Group reviewed its procedures and took comprehensive steps to improve its controls and processes. It regularly monitors compliance. Weir now has in place a strong ethics culture across the business.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGRBDDBGBBGGX
Date   Source Headline
8th Jun 20237:00 amRNSPricing of Sustainability-Linked Notes
7th Jun 202311:35 amRNSDirector/PDMR Shareholding
7th Jun 20239:20 amRNSStabilisation Notice
5th Jun 20238:25 amRNSWeir's commitment recognised in CCLA benchmark
1st Jun 20233:34 pmRNSTotal Voting Rights
25th May 20237:30 amRNSDirector Declaration
12th May 20234:42 pmRNSDirector PDMR shareholding
12th May 20238:19 amRNSDirector/PDMR Shareholding
3rd May 202312:55 pmRNSDirector/PDMR Shareholding
3rd May 202312:51 pmRNSTotal Voting Rights
28th Apr 20232:06 pmRNSBoard Committee Change and EE NED Appointment
27th Apr 20234:47 pmRNSAGM Voting Results 2023
27th Apr 20237:00 amRNSQ1 Trading Update
24th Apr 20235:48 pmRNSDirector/PDMR Shareholding
13th Apr 20234:50 pmRNSDirector/PDMR Shareholding
31st Mar 202312:54 pmRNSTotal Voting Rights
21st Mar 20231:41 pmRNS2022 Annual Report and 2023 Annual General Meeting
14th Mar 20232:44 pmRNSDirector/PDMR Shareholding
13th Mar 202311:29 amRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSWeir’s targets approved by SBTi
3rd Mar 202311:53 amRNSDirector/PDMR Shareholding
1st Mar 202310:29 amRNSTotal Voting Rights
1st Mar 202310:29 amRNSDividend Declaration
1st Mar 20237:00 amRNSFull Year Results
31st Jan 202312:01 pmRNSTotal Voting Rights
26th Jan 20231:19 pmRNSHolding(s) in Company
25th Jan 202311:48 amRNSHolding(s) in Company
20th Jan 20232:12 pmRNSHolding(s) in Company
17th Jan 20239:18 amRNSHolding(s) in Company
12th Jan 20233:43 pmRNSHolding(s) in Company
5th Jan 20232:41 pmRNSTotal Voting Rights
19th Dec 20223:29 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSWeir achieves ‘A’ score from CDP
7th Dec 20222:22 pmRNSHolding(s) in Company
7th Dec 20222:19 pmRNSHolding(s) in Company
5th Dec 20223:09 pmRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSCapital Markets Webinar
1st Dec 20224:57 pmRNSDirector/PDMR Shareholding
1st Dec 20224:53 pmRNSDirector/PDMR Shareholding
1st Dec 20224:51 pmRNSDirector/PDMR Shareholding
1st Dec 20224:48 pmRNSDirector/PDMR Shareholding
1st Dec 20224:46 pmRNSDirector/PDMR Shareholding
1st Dec 20224:41 pmRNSDirector/PDMR Shareholding
30th Nov 20224:35 pmRNSTotal Voting Rights
18th Nov 20221:21 pmRNSCapital Markets Webinar – Change of Date
9th Nov 20222:34 pmRNSDirector/PDMR Shareholding
8th Nov 202211:06 amRNSDirector/PDMR Shareholding
4th Nov 20222:37 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:22 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.